Search research articles
Contact Us
Filters
Showing results (11-20 of 29) with videos related to
Page
of 3
Sort By:
Annals of Internal Medicine
|
November 21, 2007
Brief communication: characteristics of spontaneous cases of tuberculosis associated with infliximab
Angela Raval, Gita Akhavan-Toyserkani, Allen Brinker, et al.
Dermatologic Therapy
|
May 21, 2009
Finding, evaluating, and managing drug-related risks: approaches taken by the US Food and Drug Administration (FDA)
Joyce Weaver, Lois La Grenade, Hyon Kwon, et al.
The American Journal of Gastroenterology
|
August 8, 2009
Sodium phosphate tablets and acute phosphate nephropathy
Ann Corken Mackey, Lanh Green, Keith St Amand, et al.
Journal of Child and Adolescent Psychopharmacology
|
July 17, 2007
Indication and use of drug products used to treat attention-deficit/hyperactivity disorder: a cross-sectional study with inference on the likelihood of treatment in adulthood
Allen Brinker, Andrew Mosholder, Stephanie D Schech, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
January 27, 2007
Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease
Ann Corken Mackey, Lanh Green, Li-Ching Liang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
December 15, 2020
A case series analysis of serious exacerbations of viral hepatitis and non-viral hepatic injuries in tocilizumab-treated patients
Ann Biehl, Lisa Harinstein, Allen Brinker, et al.
JAMA Internal Medicine
|
August 29, 2022
Acute Cholecystitis Associated With the Use of Glucagon-Like Peptide-1 Receptor Agonists Reported to the US Food and Drug Administration
Daniel Woronow, Christine Chamberlain, Ali Niak, et al.
Pharmacoepidemiology and Drug Safety
|
September 30, 2008
An evaluation of a data mining signal for amyotrophic lateral sclerosis and statins detected in FDA's spontaneous adverse event reporting system
Eric Colman, Ana Szarfman, Jo Wyeth, et al.
Journal of the American Academy of Dermatology
|
April 26, 2011
Progressive multifocal leukoencephalopathy associated with efalizumab use in psoriasis patients
Namita Kothary, Ida-Lina Diak, Allen Brinker, et al.
Pharmacoepidemiology and Drug Safety
|
February 12, 2009
Rhabdomyolysis reports show interaction between simvastatin and CYP3A4 inhibitors
Christopher Rowan, Allen D Brinker, Parivash Nourjah, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 29) with videos related to
Sort By:
Page
of 3
Annals of Internal Medicine
|
November 21, 2007
Brief communication: characteristics of spontaneous cases of tuberculosis associated with infliximab
Angela Raval, Gita Akhavan-Toyserkani, Allen Brinker, et al.
Dermatologic Therapy
|
May 21, 2009
Finding, evaluating, and managing drug-related risks: approaches taken by the US Food and Drug Administration (FDA)
Joyce Weaver, Lois La Grenade, Hyon Kwon, et al.
The American Journal of Gastroenterology
|
August 8, 2009
Sodium phosphate tablets and acute phosphate nephropathy
Ann Corken Mackey, Lanh Green, Keith St Amand, et al.
Journal of Child and Adolescent Psychopharmacology
|
July 17, 2007
Indication and use of drug products used to treat attention-deficit/hyperactivity disorder: a cross-sectional study with inference on the likelihood of treatment in adulthood
Allen Brinker, Andrew Mosholder, Stephanie D Schech, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
January 27, 2007
Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease
Ann Corken Mackey, Lanh Green, Li-Ching Liang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
December 15, 2020
A case series analysis of serious exacerbations of viral hepatitis and non-viral hepatic injuries in tocilizumab-treated patients
Ann Biehl, Lisa Harinstein, Allen Brinker, et al.
JAMA Internal Medicine
|
August 29, 2022
Acute Cholecystitis Associated With the Use of Glucagon-Like Peptide-1 Receptor Agonists Reported to the US Food and Drug Administration
Daniel Woronow, Christine Chamberlain, Ali Niak, et al.
Pharmacoepidemiology and Drug Safety
|
September 30, 2008
An evaluation of a data mining signal for amyotrophic lateral sclerosis and statins detected in FDA's spontaneous adverse event reporting system
Eric Colman, Ana Szarfman, Jo Wyeth, et al.
Journal of the American Academy of Dermatology
|
April 26, 2011
Progressive multifocal leukoencephalopathy associated with efalizumab use in psoriasis patients
Namita Kothary, Ida-Lina Diak, Allen Brinker, et al.
Pharmacoepidemiology and Drug Safety
|
February 12, 2009
Rhabdomyolysis reports show interaction between simvastatin and CYP3A4 inhibitors
Christopher Rowan, Allen D Brinker, Parivash Nourjah, et al.
Page
of 3